Kura Oncology (KURA) Misses Q1 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q1 EPS of ($0.59), $0.04 worse than the analyst estimate of ($0.55).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
• Snowflake (SNOW) Tops Q2 EPS by 17c, Offers Guidance